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BACKGROUND & AIMS: Despite inducing an inflammatory
response, Helicobacter pylori can persist in the gastric
mucosa for decades. H pylori expression of cholesterol-a-
glucosyltransferase (encoded by cgt) is required for gastric
colonization and T-cell activation. We investigated how cgt
affects gastric epithelial cells and the host immune response.
METHODS: MKN45 gastric epithelial cells, AGS cells, and
human primary gastric epithelial cells (obtained from
patients undergoing gastrectomy or sleeve resection or gastric
antral organoids) were incubated with interferon gamma
(IFNG) or interferon beta (IFNB) and exposed to H pylori,
including cagPAI and cgt mutant strains. Some cells were
incubated with methyl-b-cyclodextrin (to deplete cholesterol
from membranes) or myriocin and zaragozic acid to prevent
biosynthesis of sphingolipids and cholesterol and analyzed
by immunoblot, immunofluorescence, and reverse transcrip-
tion quantitative polymerase chain reaction analyses. We
compared gene expression patterns among primary human
gastric cells, uninfected or infected with H pylori P12 wt or
P12Dcgt, using microarray analysis. Mice with disruption ofthe IFNG receptor 1 (Ifngr1–/– mice) and C57BL6 (control)
mice were infected with PMSS1 (wild-type) or PMSS1Dcgt H
pylori; gastric tissues were collected and analyzed by reverse
transcription quantitative polymerase chain reaction or
confocal microscopy. RESULTS: In primary gastric cells and
cell lines, infection with H pylori, but not cgt mutants, blocked
IFNG-induced signaling via JAK and STAT. Cells infected with
H pylori were depleted of cholesterol, which reduced IFNG
signaling by disrupting lipid rafts, leading to reduced phos-
phorylation (activation) of JAK and STAT1. H pylori infection
of cells also blocked signaling by IFNB, interleukin 6 (IL6),
and IL22 and reduced activation of genes regulated by these
signaling pathways, including cytokines that regulate T-cell
function (MIG and IP10) and anti-microbial peptides such as
human b-defensin 3 (hBD3). We found that this mechanism
allows H pylori to persist in proximity to infected cells while
inducing inflammation only in the neighboring, non-infected
epithelium. Stomach tissues from mice infected with PMSS1
had increased levels of IFNG, but did not express higher levels
of interferon-response genes. Expression of the IFNG-
response gene IRF1 was substantially higher in PMSS1Dcgt-
infected mice than PMSS1-infected mice. Ifngr1–/– mice were
colonized by PMSS1 to a greater extent than control mice.
EDITOR’S NOTES
BACKGROUND AND CONTEXT
For reasons not well-understood, Helicobacter pylori can
persist life-long in the stomach despite causing a strong
inflammatory response, increasing the risk for serious
sequelae such as ulcers and cancer.
NEW FINDINGS
By extracting cholesterol from host cells, H pylori blocks
the assembly of IFN and other cytokine receptors,
rendering the infected mucosa unable to respond
properly to inflammatory signals from stroma and
immune cells.
LIMITATIONS
Bacterial mutants for the cgt gene, which is required for
cholesterol extraction, are unable to establish an in vivo
infection, preventing a detailed analysis of its effects in
the animal model.
IMPACT
This study provides important insight into the pitfalls of
past vaccination approaches for H pylori. It also
explains how cholesterol rich diet could negatively
influence the inflammatory condition of the infected
stomach mucosa.




ATCONCLUSIONS: H pylori expression of cgt reduces cholesterol
levels in infected gastric epithelial cells and thereby blocks
IFNG signaling, allowing the bacteria to escape the host in-
flammatory response. These findings provide insight into the
mechanisms by which H pylori might promote gastric carci-
nogenesis (persisting despite constant inflammation) and
ineffectiveness of T-cell–based vaccines against H pylori.
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https://doi.org/10.1053/j.gastro.2017.12.008Ainfected with the gram-negative bacterium Heli-
cobacter pylori, which is implicated in severe gastric disease,
including peptic ulcer and adenocarcinoma.1 Colonization
takes place in the gastric mucus and eventually involves
bacterial adherence to the glandular epithelium.2 The infec-
tion is characterized by a rapid and strong nuclear factor kB
(NF-kB)–driven response,3 which leads to the recruitment
and activation of immune cells: CD4þ T cells, dominated by
the Th1 lineage4,5 play a decisive role in controlling the Hel-
icobacter load via secretion of interferon gamma (IFNG).6
This Th1 response is also fueled by type I IFNs (a/b)
released from gastric epithelial cells themselves.7 Th17 and
Th22 T cells, characterized by interleukin (IL)17 and IL22
production, also promote the inflammatory milieu, helping to
control infection.8,9 Yet, H pylori is able to escape full elimi-
nation by host immunity through an unknown mechanism,
resulting in a severe chronic inflammatory condition that
represents a crucial aspect of its pathogenesis.
Gastric epithelial cells display receptors for type I (a/b)
and type II (g) interferons, the subunits of which (IFNAR1/
IFNAR2 and IFNGR1/IFNGR2, respectively) are assembled in
specialized cholesterol-richmembranemicrodomains, knownas lipid rafts.10 Microdomain-dependent receptor activation11
triggers JAK (Janus Kinase) and STAT (signaling transducer
and activator of transcription) signaling via STAT1/2 phos-
phorylation and nuclear translocation to promote down-
stream expression of genes involved in inflammation and
defense, including interferon regulatory factors (IRF), which
further amplify the IFN response through positive feedback
via STATs.12 Gastric epithelial cells also express receptors for
IL229, which can stimulate the production of antimicrobial
factors that defend against mucosal pathogens.13
The effector mechanisms controlling colonization by
H pylori remain sparsely understood. Epithelial cells can
produce antimicrobial peptides (AMP), such as hBD3
(human b-defensin 3), which effectively kills H pylori14,15
and is induced through MAPK (mitogen-activated protein
kinase) and JAK/STAT signaling and stimulation with IFNG
or IL22.14,16–18 Strikingly, despite continued inflammation,
hBD3 is not detected in infected human gastric biopsies.15,19
We have previously shown that H pylori prevents hBD3
expression through a CagA (cytotoxin-associated gene A)-
dependent mechanism.14 However, how hBD3 remains
blocked despite IFNG and IL22 stimulation is unclear.
H pylori, which is auxotroph for cholesterol, extracts the
lipid from host membranes to incorporate it into its outer
membrane as an a-glucosylated derivative, using the enzyme
Cgt encoded by the geneHP0421 (cgt).20–22 Cgt is the first in a
series ofHpylori enzymes that cause additionalmodifications
to generate cholesteryl-6’-O-aycl-a-glucoside (aCAG) or
cholesteryl-6’-O-phosphatidyl-a-glucoside (aCPG).18 Choles-
terol glucosylation and extraction from host cells result in
lipid raft destruction and/or alteration of the membrane ar-
chitecture,21,22 which has been linked to immune evasion and
bacterial persistence.22–24 We previously reported that a
cholesterol-rich diet leads to a reduction of the H pylori load
concomitant with an increased Th1 response.22
Here, we provide insight into the underlying mechanism
by showing that the IFN response is subverted by H pylori in
gastric epithelial cells. This is caused by Cgt-dependent
cholesterol depletion, resulting in the destruction of lipid
rafts, failure of IFN receptor subunit assembly and, ulti-
mately, lack of downstream signaling. Similarly, Cgt blocks
IL6 and IL22 signaling. Our data provide evidence for
the highly effective destruction of the responsiveness of
H pylori-infected epithelium, even in the presence of strong

















Human gastric tissue specimens were obtained from
individuals undergoing gastrectomy or sleeve resection, under
the ethics approval by the Charité Ethics Committee (EA1/058/
11 and EA1/129/12). Animal experiments were performed in
mice maintained under pathogen-free conditions based on
approval by the Ethics Committee for Animal Experimentation
of the State of Berlin (G0205/12).
Cell Culture Infection and Treatment
Bacteria were collected from plates and resuspended in
RPMI 1640 (serum-free). All cells were grown to 60%
confluency, washed twice with phosphate-buffered saline, and
serum starved with RPMI 1640 for 16 hours prior to experi-
ments. Infection was carried out under serum-starved condi-
tions at 37 C, 5% CO2 for the indicated times at multiplicity
of infection (MOI) 20 or 50. Treatment with methyl-b-
cyclodextrin (mbCD; Sigma, St. Louis, MO) was carried out for 5
hours at indicated concentrations. Biosynthesis of sphingolipids
and cholesterol was inhibited by treating cells with myriocin
(50 mmol/L; Sigma) for 72 hours and zaragozic acid (50 mmol/
L, Cayman Chemical: Ann Arbor, MI) for the last 18 hours. In
selected experiments, bacteria were treated with water-soluble
cholesterol (Sigma) at 1 mg/mL for 1 hour prior to infection.
Alternatively, polyethylene glycol (PEG)-cholesterol (10 mg/
mL; Sigma) was added to cultures during the last hour of
infection, while mock-infected cells were treated with an equal
volume containing cholesterol. After infection, recombinant
human IFNG (R&D Systems: Minneapolis, MN; 10 ng/mL), IFNB
(PBL Assay Science, Piscataway, NJ; 2300 U/mL), IL6 (Pepro-
tech, Rocky Hill, NJ; 25 ng/mL) or IL22 (Peprotech; 50 ng/mL)
were added to selected wells and maintained for indicated
times until the end of the experiment.
Primary Gastric Epithelial Air-Liquid Interface
Cultures. Cells from organoids or freshly isolated glands
were seeded in trans-well inserts (Millipore (Merck): Darm-
stadt, GE; PIHP01250) in 24-well plates and wells filled with
400 mL primary cell culture medium. Once cells had formed a
confluent monolayer, medium on top of the cells was removed
to start air-liquid interface (ALI) culture. Cultures were kept at
37C, 5% CO2 in a humidified incubator. Ten days later cells
were infected by placing 50 mL of bacteria in phosphate-
buffered saline (MOI 100) on top of the filters for 3 days.
For further information see Supplementary Materials and
Methods. All RT-qPCR primers listed in Supplementary Table 1.
Data Deposition. Microarray data have been deposited
in the Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.gov/
geo/) of the National Center for Biotechnology Information
under GEO accession number GSE76589.
Results
H pylori Blocks JAK/STAT Signaling
upon IFNG Treatment
To assess the influence of H pylori on the response to
IFNG, we infected MKN45 gastric epithelial cells with strainsP12 and P1 for 6 or 24 hours, followed by treatment with
IFNG for 30 minutes. Immunoblotting revealed STAT1
phosphorylation in response to IFNG treatment in non-
infected cells, cells infected with heat-killed bacteria, and
cells infected for 6 hours (Figure 1A). Surprisingly, after
prolonged infection (24 hours) IFNG stimulation failed to
activate STAT1, irrespective of theH pylori strain (Figure 1A).
To analyze the dynamics of this phenotype, we performed a
time course experiment, showing that STAT1 phosphoryla-
tion was diminished after 16 hours and completely blocked
from 24 until 96 hours of infection with P12 (Supplementary
Figure 1A). To investigate the underlying mechanisms, we
thus chose the 24 hour time point of infection as a reference.
In AGS cells, too, 24 hours of infection inhibited the response
to IFNG (Supplementary Figure 1B). MOI 10 was sufficient to
partially block IFNG signaling inMKN45 cells within 24 hours
and a complete block was observed with MOI 50
(Supplementary Figure 1C), which was therefore chosen for
further experiments.
Upon IFNG stimulation, an activated IFNGR complex
phosphorylates JAK1 and JAK2 kinases, which in turn
phosphorylate STAT1. After 24 hours of infection with P12
or P1, neither JAK1 nor JAK2 was phosphorylated any more
in MKN45 cells (Figure 1B and 1C, middle panel;
Supplementary Figure 1D). Notably, JAK1 (Figure 1B) and
JAK2 (data not shown) were activated in non-infected
MKN45 cells even without IFNG stimulation; however, this
was also diminished after infection. Infection conditions did
not compromise cell viability (Supplementary Figure 1E).Cgt is Required for Inactivation of
IFNG-JAK/STAT1 Pathway
To identify the bacterial factor involved in the block of
IFNG signaling, we infected MKN45 cells with H pylori wild
type and mutant strains. As a recent report linked CagA
translocation to STAT1 dephosphorylation via SHP-2 acti-
vation,25 we tested deletion mutants for cagPAI, which
encodes the entire type IV secretion system, cagA and cgt.
While the cagA and cagPAI mutant strains still inhibited
JAK/STAT1 signaling upon IFNG stimulation, the cgt mutant
did not (Figure 1D and Supplementary Figure 1B). Immu-
nofluorescence analysis showed that P12Dcgt (Figure 1C
and Supplementary Figure 1D) did not block JAK2 activation
upon IFNG treatment, despite adhering to epithelial cells at
levels comparable to wild type. Similarly, STAT1 signaling
upon IFNG treatment was still inhibited in a Cgt-dependent
manner at 48 h.p.i. (Supplementary Figure 1F). Although
genetic complementation of the cgt-mutant strain only
partially reconstituted Cgt expression (Supplementary
Figure 1G), it was enough to restore the ability to impair
JAK/STAT1 activation (Figure 1E) in MKN45 cells. Finally,
we evaluated the consequences of disrupted JAK/STAT1
signaling by analyzing expression of downstream genes af-
ter IFN treatment, by infecting MKN45 cells for 24 hours
with P12 wild type or P12Dcgt prior to treatment with IFNG
for 2.5 or 5 hours, followed by reverse transcription–
quantitative polymerase chain reaction (RT-qPCR). Expres-
sion of IRF1, as well as the T-cell attractant chemokines MIG
Figure 1. Prolonged infection prevents IFNG-induced activation of JAK1, JAK2, and STAT1 through Cgt activity. MKN45 cells
were infected with the indicated strains (HK, heat killed) at MOI 50 and treated (þ) or mock-treated (-) with IFNG (10 ng/mL, 30
minutes) at the indicated times post-infection (p.i.). (A and B) Immunoblot analysis of total protein level and phosphorylation of
JAK1 or STAT1, respectively. (C) Analysis of JAK2 phosphorylation (red) by confocal IF, maximum projection. Cells were non-
infected (NI) or infected with indicated H pylori strains (green) and treated with IFNG (10 ng/mL, 30 minutes). Scale bar ¼ 5 mm.
(D and E) Immunoblot analysis JAK1 and STAT1 phosphorylation and total protein levels of MKN45 cells infected or mock-
infected (NI) for 24 hours at MOI 50 with the indicated H pylori strains and treatment with IFNG (10 ng/mL, 30 minutes).




ATand IFNG-inducible protein 10 (IP)-10 (encoded by CXCL9
and CXCL10 genes, respectively), was strongly up-regulated
in non-infected cells upon IFNG treatment (Supplementary
Figure 1H). Cells infected with P12Dcgt also responded to
IFNG, but after infection with wt P12 the response was
significantly reduced. Accordingly, Cgt activity blocks the
JAK/STAT1 pathway, as well as transcription of downstream
genes involved in amplification of the IFNG response.Inhibition of IFNG Response is Linked
to Host Cholesterol Depletion, Lipid Raft
Disruption, and IFNGR Assembly
Cholesterol acquisition by H pylori has been linked to
the destruction of lipid rafts in epithelial cells.22 Lipid
rafts serve as platforms for cell signaling cascades, includingIFN signaling.26 As previously described,22 we observed
cholesterol depletion in cells infected with wild-type
H pylori (Supplementary Figure 2A). To connect this to the
block of the IFNG response, we treated cells with mbCD,
which depletes cholesterol from eukaryotic membranes.
Treatment did not affect cellular viability (Supplementary
Figure 2B) but impaired both JAK1 and STAT1 phosphory-
lation (Figure 2A). We also inhibited the biosynthesis of
sphingolipids and cholesterol by combined treatment with
myriocin and zaragozic acid to disrupt lipid raft function.11
Myriocin and zaragozic acid treatment indeed significantly
blocked the induction of IRF1 expression in response to
IFNG (Supplementary Figure 2C). In addition, when we
coated H pylori with water-soluble cholesterol before
infection to abolish cholesterol transfer from host cells, they
did not block the cellular response to IFNG treatment
Figure 2. Cholesterol depletion by H pylori blocks IFNG signaling by disrupting lipid rafts, impairing IFNGR complex assembly.
(A) Immunoblot analysis of JAK1/STAT1 phosphorylation after 5 hours mbCD treatment at indicated concentrations or in non-
treated cells (-), with or without IFNG treatment (10 ng/mL, 30 minutes). (B) Immunoblot analysis of JAK1 and STAT1 phos-
phorylation upon IFNG treatment (þ). MKN45 cells were infected for 24 hours with the indicated strains or non-infected, then
treated with IFNG (þ) (10 ng/mL, 30 minutes). Cholesterol-coating of bacteria was started 1 hour before infection and applied
to non-infected cells accordingly. (C) Immunoblot analysis of STAT1 phosphorylation upon IFNG and/or PEG-cholesterol
treatment. MKN45 cells were infected for 24 hours with H pylori wt or non-infected. In selected wells (þ), PEG-cholesterol
(5 mg/mL) was added during the final hour of infection. Then, cells were treated with IFNG (10 ng/mL, 30 minutes) (þ) or
mock-treated (-). Quantification: band intensity ratio STAT1pY:actin. (D) Confocal microscopy analysis (x-y sections with
lateral views along dotted lines: x-z, bottom; y-z right) of the lipid raft marker GM1 (green) in membranes of cells non-infected
or infected for 24 hours with indicated strains. Nuclei stained with DAPI (blue). Scale bar: 5 mm. (E) Immunoblot analysis of
detergent-resistant membranes for IFNGR1, IFNGR2, caveolin, or dot blot analysis with CTxB-HRP. Cells were non-infected or
infected for 24 hours with indicated strains, followed by treatment (þ) or mock-treatment (-) with IFNG (10 ng/mL, 30 minutes).
(F and G) Immunoprecipitation (IP) and immunoblot analysis of IFNGR subunits 1 and 2. IFNGR2 was pulled down using
IFNGR2 antibody. MKN45 cells were infected with H pylori P12 wt or coated with water-soluble cholesterol before infection.
Results representative of 2 independent experiments.













AT(Figure 2B). Cholesterol coating also restored the capacity of
wt H pylori-infected cells to up-regulate IRF1 in response to
IFNG, at levels comparable to non-infected cells
(Supplementary Figure 2D). Cholesterol coating did not
affect bacterial viability (Supplementary Figure 2E). To
control for any effects on the initial host-pathogen interplay
(eg, by masking bacterial adhesins), we repeated theexperiment by adding PEG-cholesterol to the medium
during the last hour of infection. This partially rescued the
capacity of infected cells to respond to IFNG treatment,
further highlighting the importance of cholesterol as a
mediator of inflammation in response to H pylori (Figure 2C).
The IFNGR subunits 1 and 2 need to merge at
cholesterol-rich micro-domains11 to respond to IFNG





Figure 4. Cgt prevents IFNB-, IL6-, and IL22-induced signaling in epithelial cells upon prolonged infection and impairs hBD3
expression. (A) Immunoblot analysis of STAT1 pathway activation in MKN45 cells. Cells were infected for 24 hours with
indicated strains or non-infected, then treated (þ) or mock-treated (-) with IFNB (2300 U/mL) for 30 minutes. (B and C)
Immunoblot analysis of STAT3 activation in MKN45 cells infected for 24 hours with indicated strains or treated with mbCD (5
mg/mL) for 5 hours, followed by 30 minutes with (B) IL6 (100 ng/mL) or (C) IL22 (50 ng/mL). (D and E) RT-qPCR analysis of
hBD3. MKN45 cells were non-infected or infected with indicated strains for 24 hours. IFNG (10 ng/mL) (D) or IL22 (50 ng/mL) (E)
were then added to selected wells for the specified times. To represent the net response to cytokines, results are normalized
against relative gene expression of corresponding non-infected, P12 wt and P12Dcgt infected cells. Data represented as
mean ± SD. ns, non-significant, **P <.01.













ATstimulation and initiate downstream signaling via JAK1 and
JAK2.10,27 We investigated the impact of H pylori on the
integrity of lipid rafts by assessing potential alterations in
the assembly of functional IFNGR. According to immuno-
fluorescence analysis, surface accumulation of glyco-
sphingolipid ganglioside GM1, a constituent marker of lipid
rafts, is lost after infection with P12 wt and P12DcagA
(Figure 2D, quantification of the relative membrane GM1
signal in Supplementary Figure 2F). In contrast, infection
with P12Dcgt did not notably alter GM1 distribution
(Figure 2D and Supplementary Figure 2F). In addition, we
performed a membrane fractionation to separate lipid rafts
as detergent-resistant membranes. In control cells, fractions
containing cholesterol-rich micro-domains, identified by the
presence of raft markers GM1 or caveolin, partitioned in top=
Figure 3. IFN response triggered by H pylori in vivo is ineffective.
infected with PMSS1 wt or PMSS1Dcgt. Each point represent
sented. **P <.01. (B) RT-qPCR analysis of IFNG and IRF1 expres
fold-change to respective expression of mGAPDH. Data represe
microscopy image of longitudinal stomach sections of mice
(phalloidin, red), H pylori (green), and nuclei (DAPI, blue). Sca
analysis of IFNG and IRF1 expression in samples taken from c
as in (B).fractions (Supplementary Figure 2G). Combining these
fractions for Western blot analysis showed that GM1 as well
as IFNGR1 were lost in detergent-resistant membranes
upon infection with wild-type P12 but not P12Dcgt,
regardless of IFNG treatment (Figure 2E). In total lysates,
IFNGR1 and IFNGR2 were detected in all conditions
(Supplementary Figure 2H). Finally, we performed immu-
noprecipitation of IFNGR subunit 2 to test co-precipitation
of IFNGR1. Immunoprecipitation specificity was controlled
for by absence of the transferrin receptor CD71, a protein
not associated with lipid rafts or the IFNGR complex
(Supplementary Figure 2I). In line with recent findings,11
MKN45 cells showed constitutive oligomerization of
IFNGR subunits even in the absence of IFNG (Figure 2F).
Despite this, prolonged wt H pylori infection but not(A) Bacterial clearance in C57BL6 wt and Ifngr1 -/- mice orally
s CFU counts for individual mice. Mean ± SD is also repre-
sion in stomachs of infected wt and Ifngr1 -/- mice, shown as
nted as mean ± SD. ns, non-significant, *P <.05. (C) Confocal
orally infected with PMSS1 for 2 weeks, labelled for actin
le bars: 1000 mm (upper) and 100 mm (lower). (D) RT-qPCR
orpus or antrum of the mice used in (C), results represented




ATP12Dcgt abolished assembly of receptor subunits. Coating
H pylori with exogenous cholesterol prior to infection
restored assembly of IFNGR subunits (Figure 2G). Together,
these data suggest that subversion of JAK/STAT1 signaling
by H pylori takes place at the very top of the pathway, by
preventing assembly of IFNG receptor subunits through
lipid raft destruction.
H pylori Blocks the IFNG Response
In Vivo in a Cgt-Dependent Manner
Reportedly, H pylori cgt mutants are unable to colonize
mice.21,22 Because Cgt activity is required for the block of
the IFNG response, which in turn protects against H pylori
in vivo,6 we investigated whether the IFNG response is
linked to bacterial clearance. After 3 days of infection
PMSS1Dcgt was already undetectable in wild-type mice
(Figure 3A). Mice infected with PMSS1 or PMSS1Dcgt pre-
sented similar IFNG levels in the stomach; however, the
induction of the IFNG downstream response gene IRF1 was
substantially higher in PMSS1Dcgt-infected mice
(Figure 3B). Next, we infected mice for 2 weeks with PMSS1
to allow a stronger Th1 response to develop. We observed a
corpus-predominant gland occupation by H pylori in all
analyzed mice (Figure 3C). Notably, the IFNG expression
(Figure 3D, left) was higher compared with the less colo-
nized antrum. However, IRF1 expression remained at
similar levels (Figure 3D, right). Infection with wild-type
H pylori thus leads to increased levels of IFNG, but fails to
increase expression of interferon response genes, consistent
with the notion of a Cgt-dependent block. Finally, although
we reasoned that H pylori PMSS1Dcgtmight be able to infect
Ifngr1-knock out mice (Figure 3A, right), this was not the
case. Knockout mice did show increased colonization by
wild-type PMSS1, indicating that additional defense-related
pathways apart from IFNG might contribute to the
clearance of PMSS1Dcgt.
Cholesterol Depletion by H pylori Inhibits
Type I IFN, IL6, and IL22 Signaling and
Downstream hBD3 Response
Lipid raft integrity is also known to be required for type
I IFNs and IL6 signaling.10,28 In congruence, we observed
that H pylori P12 also inhibited IFNB-induced STAT1
signaling in MKN45 cells, and this effect was dependent on
the presence of cgt but not cagA or cagPAI (Figure 4A). Also,
mbCD treatment inhibited IFNB signaling in a dose-
dependent manner (Supplementary Figure 3A). Similarly,
wild-type infection and mbCD treatment, but not infection
with the cgt mutant, prevented STAT3 phosphorylation
upon IL6 treatment (Figure 4B). IL22 is a crucial cytokine
for mediating the epithelial defense against mucosal path-
ogens. Binding to receptors in epithelial cells triggers STAT3
activation, inducing expression of antimicrobial factors.13
Again, 24-hour infection with wt P12 but not a P12Dcgt
mutant strain inhibited IL22 signaling transduction in
epithelial cells (Figure 4C); the block was also observed
upon mbCD treatment (Figure 4C). Genetic rescue of the cgt
mutant partially restored the bacterial capacity to blockIL22 signaling (Supplementary Figure 3B). Because IL22
signaling has not previously been reported to depend on
cholesterol, we demonstrated restoration of IL22 signaling
by adding PEG-cholesterol to MKN45 cells before IL22
stimulation (Supplementary Figure 3C).
Because IFNG and IL22 are reported to induce epithelial
expression of hBD3,29 a potent defensin against
H pylori,15,19 we tested the impact of infection on the
cytokine-induced hBD3 response. Infection of MKN45 cells
for 24 hours with P12Dcgt but not P12 wt, followed by
treatment with IFNG for 5 hours, induced a significant in-
crease of hBD3 transcription (Figure 4D, left), which was
evenmore dramatic after 24-hour IFNG treatment (Figure 4D,
right). In contrast, the increase over time in non-infected
and P12 wt-infected cells was minimal. Similarly, IL22 treat-
ment also induced hBD3 expression in P12Dcgt-infected cells,
albeit to a lower extent, following a similar time course as
IFNG (Figure 4E). In summary, H pylori blocks the production
of hBD3 in epithelial cells stimulated with IFNG or IL22.
Interestingly, co-stimulation with a cgt-deficient strain
induced substantially higher hBD3 expression compared with
cytokine treatment alone. Overall, these data confirm that
cholesterol depletion byHpylorinot only inhibits the response
to IFNG, but also type I IFNs, IL6, and IL22.
Inhibition of JAK/STAT Signaling in Human
Primary Gastric Epithelial Cells
We next used human gastric primary cultures30,31 to
validate our observations during authentic host-pathogen
interaction. Cells derived from primary gastric antral orga-
noids were seeded on plastic and infected with H pylori
under serum starvation before IFNG or IFNB treatment
for 30 minutes. Similar to results obtained with MKN45,
H pylori P12, but not P12Dcgt, prevented JAK1/STAT1
phosphorylation (Figure 5A). These differences were also
observed at higher MOI and in cells isolated from the corpus
region (Supplementary Figure 4A), independent of donors
(Supplementary Figure 4B). In contrast to cancer cell lines,
primary gastric epithelial cells did not exhibit constitutive
JAK1 activation (Figure 5A). Block of IFNG signaling was
observed at 24 hours post-infection, but not at earlier time
points (Supplementary Figure 4C) or with a low MOI
(Supplementary Figure 4D). Cholesterol-coated bacteria,
however, failed to block JAK/STAT1 signaling (Figure 5B).
Further, block of IFN signaling, as determined by the
up-regulation of the type II IFN-activated gene CXCL9 in
response to IFNG stimulation, was observed in H pylori P12
wt, P12DcagA, P12DcagPAI, or P12DvacA, but not in
P12Dcgt-infected cells (Supplementary Figure 4E). More-
over, H pylori P12 wt, but not P12Dcgt, inhibited STAT3
phosphorylation upon IL22 treatment at 24 hours post-
infection (Figure 5C). Genetic rescue of P12Dcgt restored its
capacity to block the response to IFNG and IL22 in primary
epithelial cells (Supplementary Figure 4F and G).
To assess the global cellular response to infection with
H pylori P12 wt or P12Dcgt, we performed microarray
analysis with human primary gastric cells infected with P12
wt or P12Dcgt. Gene Ontology term enrichment analysis
revealed responsiveness for genes involved in ‘response to
Figure 5. Cgt blocks IFN signaling in primary gastric epithelial cells. Human primary gastric cells were infected with indicated
strains at MOI 20 for 24 hours or non-infected. (A) Immunoblot analysis of JAK1/STAT1 pathway activation. After infection cells
from antrumweremock-treated or treated for 30minuteswith IFNG (5 ng/mL) or IFNB (2300U/mL). Quantification: band intensity
ratio STAT1pY: actin. (B) Cholesterol-coating of bacteria was started 1 hour before infection and applied to non-infected cells
accordingly. Afterwards cells were mock-treated or treated for 30 minutes with IFNG (5 ng/mL). Result representative of 2
independent experiments. (C) Immunoblot analysis of STAT3 activation. Cells from antrum were infected for 24 hours with
indicated strains and after infection treated for 30minutes with IL22 (50 ng/mL). (D and E) Primary human cells were infected with
H pylori P12 wt or P12Dcgt for 26.5 hours and microarray results compared with those obtained in non-infected (n.i.) cells.
Results shown are from 2 independent experiments with cells obtained from 2 independent donors. (D) Gene Ontology pro-
cesses enrichment (Panther) from up-regulated genes in n.i. vs. P12 wt data set. In all cases P< .05. (E) NF-kB-response genes
differentially modulated in n.i. vs. P12 wt and n.i. vs P12Dcgt datasets. In all cases, fold change > 1.5 and P value <.05.













ATexternal stimuli,’ ‘signal transduction,’ and ‘immune
response,’ which was similar for both wt and P12Dcgt-
infected cells (Figure 5D, and data not shown). Many of the
pro-inflammatory genes up-regulated upon infection with
either strain are related to NF-kB signaling (Figure 5E).
Therefore, while H pylori effectively blocks the response to
IFNG, IFNB, and IL22 in normal human gastric epithelial
cells, initial sensing of the pathogen by NF-kB3 remains
largely unaffected.H pylori Generates Micro-Niches of
Diminished Inflammatory Response
To spatially resolve the effects H pylori exerts, we
examined the resulting cellular phenotypes over longerperiods of time using a novel infection model of human
gastric primary cells in air-liquid interphase culture.32 This
model enables longer infection times and resembles the
in vivo situation more closely because it features greater cell
type diversity, a protective layer of mucin, and cell polari-
zation (Supplementary Figure 5A). After 3 days of infection
with P12 wt at MOI 100, cells were treated with IFNG for 30
minutes and analyzed by immunofluorescence. Interest-
ingly, IFNG treatment led to nuclear translocation of
phospho-STAT1 (Figure 6A, middle panel). Micro-colonies of
spiral-shaped bacteria (red) formed infection foci (Figure 6B
and Supplementary Figures 5A and B) correlating with areas
of reduced phospho-STAT1 exhibition (Figure 6A, bottom
panel). At lower magnification, areas of reduced STAT1
activation appeared to clearly correlate with infected areas,
Figure 6. Block of cytokine responses in infected ALI cultures. Primary human cells grown on filters were infected with P12 wt
at MOI 100 for 3 days or mock-infected (NI), then mock-treated or treated for 30 minutes with IFNG (10 ng/mL) (A and B) or
IL22 (50 ng/mL) (C) and fixed with PFA. Filters were labelled with DAPI (DNA, blue) and antibodies against H pylori (red) and
analyzed by whole-mount IF. (A) Analysis of STAT1 phosphorylation. Filters were labelled with phalloidin (green) and STAT1-pY
(white). Scale bar: 20 mm. (B) Analysis of STAT1 phosphorylation, lower magnification. Filters were labelled with antibodies
against STAT1-pY (white). Scale bar: 50 mm. (C) Analysis of STAT3 phosphorylation. Filters were labelled with antibodies
against STAT3-pY (white). Scale bar: 20 mm.









host cell cholesterol by H
pylori’s Cgt disrupts lipid
rafts and thereby prevents
assembly of IFNG re-
ceptors. In infected cells
this leads to a shutdown of
JAK/STAT1 signaling,
inhibiting the production of
T-cell chemo-attractants
and antimicrobial peptides
like hBD3. With this
mechanism, H pylori cre-
ates micro-niches of
locally diminished inflam-
mation, despite a marked
global immune response.













ATwhile non-infected areas of the same filter responded
normally to IFNG (Figure 6B). Next, we quantified the
number of phospho-STAT1–positive cells in infected
compared with non- or less well-infected microscopic
fields of the same filter. The vast majority of infected areas
displayed phospho-STAT1 levels below the activation
threshold, while non-infected fields exhibited a robust IFNG
response (Supplementary Figure 5C). Infection with the
P12Dcgt mutant at MOI 200 led to similar colonization
densities, yet the infected monolayer exhibited full STAT1
phosphorylation upon IFNG similar to non-infected cells
(Supplementary Figure 5D). Similarly, H pylori infection also
hampered STAT3 phosphorylation upon IL22 treatment in
infected areas (Figure 6C). Thus, using an advanced
epithelial cell culture model, we demonstrate that H pyloriprevents infected cells from responding to IFNG or IL22.
This favors the formation of micro-colonies at micro-niches
devoid of STAT1 or STAT3 activation. Although non-infected
sites of the same culture retain full responsiveness, this does
not halt micro-colony formation at protected sites.Discussion
A hallmark of gastric infections with H pylori is the
strong NF-kB–driven response of the epithelium. This initi-
ates a chronic inflammatory condition fueled by the
recruitment of immune cells, which produce IFNs4,6 and
other cytokines, including IL22.13 These cytokines trigger a
second wave of epithelial responses, characterized by the
release of defensins and other bactericidal factors, to




ATrestrict pathogen growth.29 As we report here, H pylori
evolved a powerful means to prevent infected epithelial
cells from responding to this cytokine burst – shutting
down bactericidal activity right at the site of infection.
This intriguing phenomenon, exerted by the bacterial
enzyme Cgt, is in line with previous observations that point
to an unexplained inhibition of IFNG-induced nuclear
translocation of STAT1 during H pylori infection.33 Our
findings now provide the mechanistic clue to our earlier
characterization of cgt as a critical determinant of H pylori
immune evasion.22
The gastric mucosa of patients exhibits a marked
prevalence of pro-inflammatory cytokines and mediators
that provoke innate and Th1-, Th17-, and Th22-driven
immune responses.8,9,34,35 However, IFNG and IL17 merely
control, rather than clear, established infections. Similarly,
IL22 induces the production of relevant antimicrobial fac-
tors in gastric epithelial cells, but surprisingly IL22
knockout and wt mice show similar H pylori colonization
rates.18 Previous work identified the H pylori factors VacA
and GGT as immune modulators that impair the activation
and proliferation of T cells.5,36 They skew normal T-cell
maturation from Th1 and Th17 toward a Treg phenotype
and thereby elicit a considerable degree of local and sys-
temic tolerance.37 Although this deficit of T-cell maturation
can be rescued by vaccination, vaccine-driven T-cell acti-
vation normally achieves only a reduction of the bacterial
load concomitant with an increased inflammation.38 This
paradox points to a block of the T-cell–mediated immunity
at the effector side of host epithelial defense, which can be
explained by the action of Cgt. Because Cgt acts only on
infected cells, this gives rise to an intriguing scenario: while
inflammation prevails in the infected tissue, Cgt generates
protected islands of diminished defense, promoting path-
ogen survival. Indeed, this notion is corroborated by
observations with chronically infected mice challenged with
a secondary H pylori infection39: newly incoming bacteria
were unable to colonize infected mice except for a few
glands already occupied by the primary infection, pointing
toward an overall anti-microbial environment in the infec-
ted stomach. Together these observations suggest that
H pylori forms protected micro-niches surrounded by an
otherwise inflamed and microbicidal milieu (Figure 7).
Amongst the T-cell chemotactic factors affected by Cgt
are MIG and IP-10, which contribute to protection against
H pylori.7,40 Homeostasis of the mucosal colonization by
H pylori, avoiding an excessive bacterial load, is thought to
be achieved through secretion of a variety of innate
factors, including defensins, mucins, and oxidative metabo-
lites.15,41,42 Many of these are produced by the epithelium in
response to IFNG and IL22.13,16,17 hBD3, one of the most
potent factors against H pylori, is induced in an IFNG-
dependent manner in the context of chronic gastrointes-
tinal inflammation.15,16 We have previously observed that
EGFR-dependent induction of hBD3 is down-regulated upon
translocation of H pylori CagA via the activation of SHP-214
and CagA-dependent activation of SHP-2 also interferes with
IFNG signaling.25 Thus, CagA acts synergistically with Cgt in
preventing IFN signaling and hBD3 synthesis, with Cgtexpressed also in strains that lack the cagPAI T4SS. Our
results, however, show a minimal contribution of CagA in
blocking JAK/STAT signaling, possibly because of variations
in the active motifs of CagA proteins in our European strain
as compared with Asian strains,43 such as the one used by
Wang and colleagues.25 Consistently, biopsies from Euro-
pean patients exhibited poor bactericidal activity against
H pylori and lack of hBD3, regardless of whether they were
cagPAI/cagA positive or negative.15,19
Lipid rafts are also targeted by other pathogens known
to block IFN signaling (such as West Nile virus), which
modifies the distribution of lipid rafts in the membrane44
and Leishmania donovani, which disrupts lipid rafts in
macrophages to inhibit assembly of IFNGR subunits.27 Here,
using H pylori, we achieve striking mechanistic insights into
microbial cholesterol depletion from host cells, an appar-
ently common, yet little appreciated virulence strategy.
Accordingly, cholesterol depletion prevents the partitioning
of IFNGR1 to lipid rafts and association with IFNGR2 sub-
units.27 In MKN45 cells, we observed an association of
IFNGR2 and IFNGR1 subunits even in the absence of infec-
tion, consistent with the abnormal, constitutive JAK1/2
activation. However, this association collapsed upon H pylori
infection, rendering these cells unresponsive, independently
of the presence of interferons.
Our in vivo experiments confirmed a Cgt-dependent
block of the IFNG response, with the results obtained in
Ifngr1 knockout mice indicating that additional pathways
contribute to preventing colonization with the PMSS1Dcgt
mutant. This finding is consistent with the inhibitory action
of Cgt on multiple lipid raft-dependent pathways, including
IL6 and IFNB,10,28,44 and IL22, in addition to IFNG. Vice
versa, Cgt may also cause receptor activation such as for
EGFR and TGFBR, where cholesterol depletion increases the
number of molecules available for ligand binding.26,45,46
Apart from this, many signaling routes, particularly those
involving the pro-inflammatory pathway NF-kB, appear to
function normally in H pylori-infected cells, even at a time
when cholesterol depletion has progressed.
We have substantiated our findings in primary epithelial
cells from different donors. Importantly, the use of cells
from human gastric organoids allowed us to address bio-
logical questions in a mutation-free background.30 Although
primary cell models are increasingly used to address
questions of infection biology,47 little data related to H py-
lori are available yet. Here, we also utilized an advanced ALI
model, which offers several improvements: (i) cultures grow
under the influence of Wnt to maintain stemness; (ii) cells
differentiate toward a diversity of cells, including pit, neck,
chief, parietal, and neuroendocrine cells; (iii) cell polariza-
tion and secretion of a protective mucus layer supports an
authentic equilibrium between cells and bacteria, enabling
long-term infection.32
As we have previously shown, dietary cholesterol sup-
plementation significantly reduces the H pylori burden in
mice.22 The decreased colonization came at the cost of
substantially increased IFNG-driven inflammation. Our cur-
rent results, together with the established link between lipid
rafts and IFN signaling,10,27 are in complete agreement with
April 2018 H Pylori Blocks IFNG Signaling 1403previous in vivo findings.22 Accordingly, cholesterol supply
in the context of H pylori infection enhances JAK/STAT
signaling together with the release of antibacterial effectors.
Such increased Th1 responses, however, are also thought to
promote preneoplastic lesions.6,48 This notion, in turn, is
consistent with the situation in patients suffering from
increased blood cholesterol levels, especially in the form of
low-density lipoprotein-cholesterol, who often exhibit se-
vere H pylori-induced gastritis.49 Accordingly, a low-
cholesterol diet may reduce the pathology of H pylori
gastric infections. This places Cgt function, cholesterol
metabolism, and inflammation at the crossroads of gastric
pathogenesis and cancer.
Supplementary Material
Note: To access the supplementary material accompanying
this article, visit the online version of Gastroenterology at
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Supplementary Figure 1. (A) Time course analysis of IFNG induced STAT1 phosphorylation by immunoblot. MKN45 cells
were infected with H pylori P12 wild type at MOI 50 or non-infected (NI). After indicated infection times, cells were treated (þ)
with IFNG (10 ng/mL, 30 minutes). (B) Immunoblot analysis of IFNG induced STAT1 phosphorylation in AGS gastric epithelial
cell line upon infection with indicated H pylori strain at MOI 50 and in non-infected cells. After 24 hours of infection, cells were
treated (þ) with IFNG (10 ng/mL, 30 minutes). (C) MOI titration analysis of IFNG induced STAT1 phosphorylation by immu-
noblot. MKN45 cells were infected with H pylori P12 wild type at indicated MOIs or non-infected (NI). After 24 hours of
infection, cells were treated (þ) with IFNG (10 ng/mL, 30 minutes). (D) Analysis of JAK2 phosphorylation (red) by confocal IF at
low magnification, confocal section. Cells were non-infected (NI), or infected with indicated H pylori strains (bacteria labeled in
green). In all cases, cells were treated with IFNG (10 ng/mL, 30 minutes). Scale bar: 10 mm. The result is representative of 3
independent experiments. (E) Cellular viability of MKN45 cells infected with indicated H pylori strains, or heat-killed P12 (P12
HK) at indicated MOIs for 24 hours. Viability was measured via a fluorescence-based ATP assay (Promega, Madison, WI). All
readings were normalized against non-infected (NI) cells. Cells treated for 5 minutes with Triton X-100 serve as control. Data
shows mean ± SD of 2 independent biological experiments. SD is derived from 3 technical replicates. (F) Immunoblot analysis
of IFNG induced JAK1 and STAT1 phosphorylation in MKN45 gastric epithelial cells after 48 hours of infection with indicated H
pylori strains at MOI 50 and in non-infected cells. At the end of infection, cells were treated (þ) or mock-treated (-) with IFNG
(10 ng/mL) for 30 minutes. Quantification shows band intensity ratio of STAT1pY:actin. (G) Immunoblot analysis of CGT
expression after genetic complementation of CGT mutant strain. 4x106 bacteria of H pylori P12 wt, P12Dcgt, DcagA, DcagPAI,
and 2 clones of the recomplemented strains Dcgt/cgt were lysed in Laemmli buffer and checked for CGT expression by using
an in-house created monoclonal anti-CGT antibody. (H) Response to IFNG for genes IRF1, CXCL9, and CXCL10 quantified by
RT-qPCR analysis. MKN45 cells were non-infected or infected with indicated H pylori strains for 24 hours. IFNG (10 ng/mL)
was then added to selected wells for the specified times. To represent the net response to IFN, results were normalized against
relative gene expression of corresponding non-infected, P12 and P12Dcgt infected cells. Data are represented as mean ± SD;
ns, non-significant, *P < .05, **P < .01.
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Supplementary Figure 2. (A) Cholesterol quantification of MKN45 upon H pylori infection. Cells were non-infected (NI) or
infected with indicated strains of H pylori for 24 hours at MOI 50. After this period, cholesterol was quantified using Amplex kit
(Invitrogen Carlsbad, CA). All readings were normalized against protein content and further normalized against cholesterol
levels in non-infected cells. Data show mean ± SD of 2 independent biological experiments with 2 technical replicates each. (B)
Cellular viability of MKN45 cells treated with mbCD (5 mg/mL) for 6 hours. Viability was measured via a fluorescence-based
ATP assay (Promega). All readings were normalized against the NI and mock-treated cells. Cells treated for 5 minutes with
TritonX-100 served as control. Data show mean ± SD of 2 independent biological experiments with 2 technical replicates each.
(C) Response to 2.5-hour treatment with IFNG (10 ng/mL) after mock treatment or treatment with myriocin (72 hours, 50 mmol/
L) plus zaragozic acid (18 hours, 50 mmol/L) (MZ). IRF1 mRNA levels obtained by qRT-PCR were normalized against respective
GAPDH mRNA expression, and further normalized against non-infected (NI) cells. Data show mean ± SD of 2 independent
biological experiments with 2 technical replicates each. For statistical analysis, MZ-treated samples were compared with
mock, IFNG-treated controls: ns non-significant, **P <.01. (D) Response to 2.5-hour treatment with IFNG for IRF1 gene in cells
infected with bacteria with or without cholesterol coating. MKN45 cells were non-infected or infected with indicated H pylori
strains for 24 hours. IFNG (10 ng/mL) was then added to selected wells for the 2.5 hours. To represent the net response to IFN,
results were normalized against relative gene expression of respective corresponding non-infected, P12 and P12Dcgt infected
cells. Data are represented as mean ± SD; ns, non-significant, **P < .01. (E) Viability of cholesterol-coated bacteria. Bacteria
(108/mL) in serum-free medium were coated or mock-coated with exogenous cholesterol (1 mg/mL) for 1 hour. Colony forming
units (CFU)/mL were quantified 3 days later. Data are expressed as percentage bacterial survival relative to the untreated P12
(without cholesterol coating). Data show mean ± SD of 2 independent biological experiments with 2 technical replicates each.
(F) Confocal microscopic analysis of the lipid raft marker GM1 (stained with CTxB-Alexa488, green) in cellular membranes of
cells non-infected (NI) or infected for 24 hours with indicated H pylori strains. Left panel corresponds to the quantification of
relative superficial GM1 signal. Results are shown as a box-plot (2nd and 3rd quartiles, median represented as horizontal line
inside the box) of the ratio between cellular membrane and correspondent cytoplasm average intensities and further
normalized to the average intensity ratio of non-infected cells of each corresponding experiment. Data correspond to 3 in-
dependent experiments; n ¼ number of analyzed cells; **P < .01. Right panel, representative images used for quantification.
Scale bar: 10 mm. (G) Immunoblot analysis of detergent resistant membrane fractions (1–10, from top to bottom) of uninfected
MKN45 cells after density gradient centrifugation for distribution of caveolin or GM1 distribution detected by dot blot with
cholera toxin B conjugated to HRP. Fractions inside the box were pooled for further analysis. (H) Immunoblot analysis of
whole cell lysate of MKN45 cells for IFNGR1, IFNGR2, or caveolin. Cells were non-infected (NI) or infected for 24 hours with
indicated H pylori strains. After infection time, cells were treated (þ) or mock-treated (-) with IFNG (10 ng/mL, 30 minutes).
(I) Immunoprecipitation (IP) and immunoblot analysis of IFNGR subunits 1, 2, and CD71. IFNGR2 was pulled down using
anti-IFNGR2 antibody.
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Supplementary Figure 3. (A) Immunoblot analysis of STAT1 phosphorylation after 5 hours mbCD treatment at the concen-
trations indicated or in non-treated cells (-). IFNB treatment (2300 U/mL, 30 minutes) was applied in selected wells. The result is
representative of 3 independent experiments. Quantification shows band intensity ratio of STAT1pY:actin (B) Immunoblot
analysis of STAT3 phosphorylation of MKN45 cells infected with indicated H pylori strains or mock-infected (NI) for 24 hours at
MOI 50 with the indicated H pylori strains, followed by treatment with IL22 (50 ng/mL) for 30 minutes. (C) Immunoblot analysis
of STAT3 activation in MKN45 cells. Cells were infected for 24 hours with H pylori P12 wild type or mock infected. In selected
wells PEG-cholesterol was added during the final hour of infection. Cells were then treated with IL22 (50 ng/mL, 30 minutes) (þ)
or mock-treated (-). Quantification shows band intensity ratio of STAT1pY:actin.
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Supplementary Figure 4. Experiment performed in 2D primary gastric human cells from different donors infected with indi-
cated H pylori strains at MOI 20 or 50 for 24 hours or non-infected (NI). (A) Immunoblot analysis of STAT1 pathway activation.
Cells from the corpus region were infected with indicated H pylori strains at different MOIs. After infection time cells were
mock-treated or treated with IFNG (5 ng/mL). (B) Immunoblot analysis of the activation of JAK1/STAT1 pathway. After
infection, cells were mock-treated or treated 30 minutes with IFNG (g) (5 ng/mL) or IFNB (b) (2300 U/mL). (C) Time course
analysis of IFNG-induced STAT1 phosphorylation by immunoblot. Cells were infected with H pylori P12 wt at MOI 20 or non-
infected (NI). After indicated infection times, cells were treated (þ) with IFNG (5 ng/mL, 30 minutes). (D) Immunoblot analysis of
STAT1 phosphorylation. Cells were infected with H pylori wild type at different MOIs or left uninfected. After infection time cells
were mock-treated or treated with IFNG (5 ng/mL). (E) Response to 2.5-hour treatment with IFNG (5 ng/mL) after infection with
indicated H pylori strains or non-infected (NI). CXCL9 mRNA levels obtained by qRT-PCR were normalized against respective
GAPDH mRNA levels, and further normalized against non-infected (NI) cells. Data show mean ± SD of 4 independent bio-
logical experiments (performed with cells from 2 different donors) with 2 technical replicates each. For statistical analysis,
infected samples were compared with uninfected, IFNG-treated controls: ns non-significant, **P < .01. Immunoblot analysis of
STAT1 (F) or STAT3 (G) phosphorylation of primary cells mock-infected (NI) or infected with H pylori P12 wt, P12Dcgt or 2
clones of the recomplemented strains Dcgt/cgt for 24 hours at MOI 50, followed by treatment with (F) IFNG (5 ng/mL, 30
minutes) or (G) IL22 (50 ng/mL, 30 minutes). Quantification of (F) shows band intensity ratio of STAT1pY:actin.
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Supplementary Table 1.Primers used in this Study













Mouse IRF1 Fwd ATCTCGGGCATCTTTCGCTT
Mouse IRF1 Rev TCTGCATCTCTAGCCAGGGT
Mouse GAPDH Fwd TCACCATCTTCCAGGAGCG
Mouse GAPDH Rev AAGCAGTTGGTGGTGCAGG
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Supplementary Figure 5. Blockage of cytokine response in infected ALI cultures. Human gastric primary cells were grown on
polycarbonate filters, infected with H pylori and analyzed by confocal IF. (A) Schematic representation of an infected ALI
monolayer. Microscopic image corresponds to a paraffin section of cells infected with P12 at MOI 100 for 3 days. Monolayers
were labelled with DAPI and antibodies against cagA (red) and E-cadherin (green) followed by IF analysis. (B) Detail at high
magnification showing infecting H pylori bacteria (labeled in red) from Figure 6B. Right image corresponds to the square-
delimited area on the left image. Scale bars: 50 mm (left), 5 mm (right). (C) Representative microscopic fields from infected
filters used for quantification of STAT1 pY-positive cells and quantification of nuclear STAT1 pY-positive cells in infected fields.
After 3 days of infection with H pylori wild type (MOI 100), cells were treated for 30 minutes with IFNG (10 ng/mL). Filters were
labelled with DAPI (DNA, blue), and antibodies against STAT1 pY (white) and H pylori (red), followed by whole mount IF. Scale
bar: 100 mm. For quantification, microscopic fields homogeneously infected (number of cells n ¼ 9548) were compared with
non- or minimally infected ones (number of cells n ¼ 15,682). Results were obtained from 4 independent infected filters and are
expressed as percentage of nuclear STAT1 pY-positive cells determined by ImageJ software. **P < .01. (D) Analysis of STAT1
phosphorylation. After 3 days of infection with H pylori P12Dcgt (MOI 200), cells were treated for 30 minutes with IFNG (10 ng/
mL), and labelled with DAPI (DNA, blue), and antibodies against STAT1 pY (white) and H pylori (red), followed by whole mount
IF. Scale bar: 50 mm.
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